Tecentriq (atezolizumab) is an immune checkpoint inhibitor used to treat non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), heptatocellular (liver) carcinoma (HCC), melanoma (skin cancer), and alveolar soft part sarcoma (ASPS), a rare soft tissue tumor.